<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD001829-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD001829-sec-0029"></div> <div class="table" id="CD001829-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span>Â <span class="table-title">Vitamin A or retinoids versus placebo for treating oral leukoplakia</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Systemic or topical vitamin A vs placebo for treating leukoplakia</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> people with oral leukoplakia<br><b>Intervention:</b> vitamin A or retinoids<br><b>Comparison:</b> placebo </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with placebo</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with vitamin A or retinoids</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cancer development at 24 months from start of treatment (treatment lasted 12 months)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>93 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>10 per 1000<br> (1 to 191) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.11<br> (0.01 to 2.05) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>85<br> (1 RCT) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>This study evaluated systemic treatment</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Clinical resolution (not completely resolved) at 4 to 12 months</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Studies could not be combined in metaâanalysis</p> <p>One study evaluated topical treatment and did not find evidence of benefit</p> <p>3 studies of systemic vitamin A â 2 showed benefit in terms of clinical resolution, and 1 did not </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Histological changes (not improved) at 3 months</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>889 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>382 per 1000 (213 to 676)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.43 (0.24 to 0.76)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>41</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>moderate</b><sup>b</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>This study evaluated systemic treatment</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety of the intervention at 4 to 12 months</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>3 studies (1 each evaluating topical acitretin, topical 13âcisâretinoic acid, 200,000 IU per week of vitamin A) found no adverse effects. Systemic 13âcisâretinoic acid (1 to 2 mg/kg/d) caused adverse effects of varying severity in 79% of participants </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; RR = risk ratio; vs = versus; d = day </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> We are very confident that the true effect lies close to the estimate of the effect<br><b>Moderate quality:</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect but may be substantially different<br><b>Low quality:</b> Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect<br><b>Very low quality:</b> We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>*</sup>From event rate in control group<br><sup>a</sup>Downgraded 3 levels as single small study at unclear risk of bias with very imprecise result<br><sup>b</sup>Downgraded as single small study </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD001829-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Systemic beta carotene or carotenoids vs placebo for treating oral leukoplakia</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Systemic beta carotene or carotenoids vs placebo for treating oral leukoplakia</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> people with oral leukoplakia<br><b>Intervention:</b> systemic beta carotene<br><b>Comparison:</b> placebo </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with placebo</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with beta carotene or carotenoids</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cancer development at</p> <p>24 months from start of treatment (treatment lasted 12 months)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>108 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>79 per 1000<br> (26 to 238) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.73<br> (0.24 to 2.20) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132<br> (2 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>1</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Clinical resolution (not completely resolved) at</p> <p>5 to 12 months</p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>The 3 studies could not be combined in metaâanalysis. 2 found benefit for systemic beta carotene, and 1 did not </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Histological changes (not improved)</p> <p>at 5 months (treatment lasted 3 months)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>833 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200 per 1000</p> <p>(100 to 383)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.24 (0.12 to 0.46)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>58</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>low</b><sup>2</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety of the intervention at 5 to 12 months</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Systemic beta carotene did not cause any adverse effects in 1 study supplementing 10 mg/d, and caused adverse effects of varying severity in 9% of participants in another study supplementing 360 mg/wk </p> <p>No adverse effects were reported by participants treated with systemic lycopene in one study </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; RR = risk ratio; vs = versus; d = day; wk = week </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but may be substantially different<br><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>*</sup> From event rate in control group<br><sup>a</sup>Downgraded 3 levels for unclear or high risk of bias and serious imprecision<br><sup>b</sup>Downgraded 2 levels as single small study at unclear risk of bias </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD001829-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span>Â <span class="table-title">Nonâsteroidal antiâinflammatory drugs (NSAIDs) vs placebo for treating oral leukoplakia</span>
</div>
<table class="summary-of-findings framed"><tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>NSAIDs vs placebo for treating oral leukoplakia</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> people with oral leukoplakia </p> <p><b>Intervention:</b> NSAIDs </p> <p><b>Comparison:</b> placebo </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with placebo</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with NSAIDs</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cancer development</p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Clinical resolution (not completely resolved) at 3 months</p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>1 study evaluated systemic treatment and 1 evaluated topical treatment. Neither found benefit for NSAIDs </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Histological changes (not improved)</p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety of the intervention</p> <p>over 3 months</p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Systemic celecoxib (1 study) â 32 intervention participants reported 56 adverse effects and 20 placebo participants in the placebo group reported 20 adverse effects. Minor adverse events included dizziness, diarrheoa and abdominal pain. 4 participants (2 from the placebo group and 2 from an intervention group) had grade 3 adverse events. 2 participants permanently discontinued treatment owing to an adverse event (grade 2 vision abnormality and hypertension in a participant receiving 400 mg twice daily of celecoxib and a grade 3 ischaemic cerebrovascular accident in a participant receiving 200 mg twice daily of celecoxib) </p> <p>Ketorolac oral rinse (1 study) caused adverse effects of varying severity in 29% of participants </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; RR = risk ratio; vs = versus </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr>
</tbody></table>
</div> <div class="table" id="CD001829-tbl-0004"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 4.</span>Â <span class="table-title">Herbal extracts vs placebo for treating oral leukoplakia</span>
</div>
<table class="summary-of-findings framed"><tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Herbal extracts vs placebo for treating oral leukoplakia</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> people with oral leukoplakia </p> <p><b>Intervention:</b> herbal extracts â tea components; a Chinese herbal mixture; curcumin chewing gum; freezeâdried black raspberry gel </p> <p><b>Comparison:</b> placebo </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with placebo</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with herbal extracts</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cancer development</p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Clinical resolution (not completely resolved) at 3 to 6 months</p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>3 studies (1 of freezeâdried black raspberry gel, 1 of green tea extract capsules and 1 of mixed tea treatment) did not find evidence of benefit for the intervention </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Histological changes (not improved) at 3 months</p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>2 studies (1 of green tea extract capsules and 1 of freezeâdried raspberry gel) did not find evidence of benefit from these interventions </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety of the intervention up to 3 months</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>3 studies measured adverse effects: green tea extract capsules caused high frequency (93%) of adverse effects of varying severity in 1 study; the mixed tea treatment study did not mention adverse effects; freezeâdried black raspberry gel did not cause any adverse effects </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; RR = risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr>
</tbody></table>
</div> <div class="table" id="CD001829-tbl-0005"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 5.</span>Â <span class="table-title">Topical bleomycin vs placebo for treating oral leukoplakia</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Topical bleomycin vs placebo for treating oral leukoplakia</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> people with oral leukoplakia<br><b>Intervention:</b> topical bleomycin<br><b>Comparison:</b> placebo </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with placebo</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with topical bleomycin</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cancer development up to 7 years</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>83 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>250 per 1000</p> <p>(27 to 1000)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 3.00<br> (0.32 to 27.83) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20<br> (1 RCT) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Clinical resolution (not completely resolved)</p> <p>at 3 months</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>917 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>504 per 1000 (266 to 954)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.55 (0.29 to 1.04)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>a</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Histological changes (not improved) at 3 months</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>818 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>401 per 1000 (180 to 900)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.49 (0.22 to 1.10)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>21</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>a</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety of the intervention up to 3 months</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>"All patients in the bleomycin group developed erythema with erosion by the end of the applications, whereas erythema developed in the placebo group. Discomfort was reported by 60% of the bleomycin group, but analgesics were not required. Taste of the topical application as wellâtolerated. There was no observed systemic toxicity in the patient groups" </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; RR = risk ratio; vs = versus </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but may be substantially different<br><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>*</sup> From event rate in control group<br><sup>a</sup>Downgraded 3 levels as a single small study at unclear risk of bias with imprecise result </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD001829-tbl-0006"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 6.</span>Â <span class="table-title">BowmanâBirk inhibitor versus placebo for oral leukoplakia</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>BowmanâBirk inhibitor vs placebo for treating oral leukoplakia</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> people with oral leukoplakia </p> <p><b>Intervention:</b> BowmanâBirk inhibitor </p> <p><b>Comparison:</b> placebo </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Number of participants<br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="2" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with placebo</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Risk with BowmanâBirk inhibitor</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Cancer development</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Clinical resolution (not completely resolved) at 6 months</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>957 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>957 per 1000</p> <p>(871 to 1000)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 1.00 (0.91 to 1.09)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>21</p> <p>(1 RCT)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>low</b><sup>a</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Histological changes (not improved) at 6 months</p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not measured</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Safety of the intervention up to 6 months</p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Trial authors reported that there were no significant adverse effects. 33 participants in the intervention group reported 75 adverse effects. 25 participants in the placebo group reported 63 adverse effects </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br> CI = confidence interval; RR = risk ratio; vs = versus </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br><b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>*</sup> From event rate in control group<br><sup>a</sup>Downgraded 2 levels as a single small study at high risk of bias </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
